Top Markets
Coin of the day
Ikonisys S.A. Ikonisys S.A.

Ikonisys S.A.

ALIKO
株式のランク #28110
Based in Paris, France, Ikonisys S.A. is a company specializing in cell-based... Based in Paris, France, Ikonisys S.A. is a company specializing in cell-based diagnostics. It develops, produces, and commercializes medical diagnostic solutions for various cancers across the United States and Europe. Their core offering includes the Ikoniscope Robotic Microscope, which automates slide manipulation, scanning, and real-time image acquisition and analysis, thereby minimizing human error during diagnostic testing. The company provides a suite of specialized oncoFISH microscopy applications for cancer detection and characterization, such as oncoFISH bladder for analyzing urine samples, oncoFISH her2 for determining HER2 status in breast tissue biopsies, oncoFISH ALK for identifying rearrangements of the ALK gene, and oncoFISH PTEN for detecting PTEN gene deletions in prostate tissue biopsies. Ikonisys also offers tools for characterizing individual circulating tumor cells (CTCs) and analyzing circulating tumor DNA (ctDNA) to provide comprehensive tumor genotype information. Additionally, their Ikonisoft explorer software suite features dedicated FISH scanning applications: Ikonisoft explorer CS for cell suspensions on slides, and Ikonisoft explorer tissue for examining hybridized tissue sections. Finally, the IkoniWAN Gateway provides a secure, validated remote access solution for their Ikoniscope digital microscopy platforms.
株価
$1.80
最終同期: 2026-08-19
時価総額
$28.48M
変化(1日)
4.11%
変化(1年)
1.79%
FR
取引 Ikonisys S.A. (ALIKO)

カテゴリー

Ikonisys S.A.(ALIKO)のP/B比率
2026 時点のP/B比率 TTM: 0
Ikonisys S.A. の最新の財務報告および株価によると、現在のP/B比率(TTM)は 0 です。2026 年末時点でのP/B比率は 0 でした。
Ikonisys S.A. の P/B 比率の履歴(2026 ~ 2026)
各年末時点のP/B比率
P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
4.9725 -
US